Citadel Buys 9.9% Stake in MEI Pharma $MEIP Boosting Interest...
Key Takeaways Citadel Advisors’ disclosure of a 9.9% passive stake in MEI Pharma has catalysed renewed investor interest, causing a notable uptick in the biopharmaceutical firm’s share price. The hedge...